A novel drug therapy for recurrent laryngeal nerve injury using T-588.

@article{Mori2007AND,
  title={A novel drug therapy for recurrent laryngeal nerve injury using T-588.},
  author={Yuko Mori and Akihiro Shiotani and Koichiro Saito and Koji Araki and Ken Ikeda and Masaya Nakagawa and Kazuhiko Watabe and Kaoru Ogawa},
  journal={The Laryngoscope},
  year={2007},
  volume={117 7},
  pages={1313-8}
}
OBJECTIVES/HYPOTHESIS We have previously shown that gene therapy using Insulin-like growth factor (IGF)-I, glial cell line-derived neurotrophic factor (GDNF), and brain-derived neurotrophic factor (BDNF), or a combination of these trophic factors, is a treatment option for recurrent laryngeal nerve (RLN) palsy. However, there remain some difficulties preventing this option from becoming a common clinical therapy for RLN injury. Thus, we need to develop novel treatment option that overcomes the… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…